David Sibon

3.3k total citations
67 papers, 1.2k citations indexed

About

David Sibon is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, David Sibon has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 20 papers in Immunology and 17 papers in Oncology. Recurrent topics in David Sibon's work include Lymphoma Diagnosis and Treatment (34 papers), T-cell and Retrovirus Studies (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). David Sibon is often cited by papers focused on Lymphoma Diagnosis and Treatment (34 papers), T-cell and Retrovirus Studies (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). David Sibon collaborates with scholars based in France, United States and Belgium. David Sibon's co-authors include Pascal Amireault, Francine Côté, Olivier Hermine, Josette Brière, Felipe Suárez, Ambroise Marçais, Eric Wattel, Corinne Haïoun, É. de Kerviler and Franck Mortreux and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Sibon

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sibon France 19 499 433 349 175 153 67 1.2k
Youko Suehiro Japan 13 128 0.3× 332 0.8× 141 0.4× 140 0.8× 90 0.6× 62 699
Dan Lehmann Israel 19 351 0.7× 598 1.4× 151 0.4× 169 1.0× 124 0.8× 36 1.2k
Ciro Manzo Italy 18 86 0.2× 509 1.2× 129 0.4× 226 1.3× 252 1.6× 80 1.2k
T Kitani Japan 17 140 0.3× 427 1.0× 122 0.3× 203 1.2× 167 1.1× 61 898
Caroline Thielen Belgium 13 408 0.8× 541 1.2× 303 0.9× 210 1.2× 23 0.2× 24 1.1k
Véra Boulay France 13 54 0.1× 591 1.4× 130 0.4× 163 0.9× 213 1.4× 13 1.1k
Neil Minton United States 11 462 0.9× 155 0.4× 133 0.4× 208 1.2× 78 0.5× 24 818
Mara Giordano Italy 20 93 0.2× 230 0.5× 81 0.2× 503 2.9× 37 0.2× 83 1.3k
Marte K. Viken Norway 20 120 0.2× 498 1.2× 91 0.3× 339 1.9× 123 0.8× 50 1.3k
Carsten Alt United States 11 302 0.6× 576 1.3× 203 0.6× 178 1.0× 51 0.3× 25 1.2k

Countries citing papers authored by David Sibon

Since Specialization
Citations

This map shows the geographic impact of David Sibon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sibon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sibon more than expected).

Fields of papers citing papers by David Sibon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sibon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sibon. The network helps show where David Sibon may publish in the future.

Co-authorship network of co-authors of David Sibon

This figure shows the co-authorship network connecting the top 25 collaborators of David Sibon. A scholar is included among the top collaborators of David Sibon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sibon. David Sibon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molinari, Nicolas, David Sibon, Anne‐Ségolène Cottereau, et al.. (2023). Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA. British Journal of Haematology. 202(2). 379–383.
2.
Isnard, Pierre, David Sibon, Jean‐Michel Goujon, et al.. (2023). Randall-Type Monoclonal IgE Kappa Light-Heavy Chain Deposition Disease. Kidney International Reports. 8(7). 1464–1468. 1 indexed citations
3.
Sibon, David. (2022). Peripheral T-Cell Lymphomas: Therapeutic Approaches. Cancers. 14(9). 2332–2332. 12 indexed citations
4.
Camus, Vincent, Aurélien Belot, Lucie Obéric, et al.. (2022). Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial. Blood Advances. 6(24). 6169–6179. 8 indexed citations
5.
Tavernier, Emmanuelle, Frédérique Kuhnowski, Jérôme Tamburini, et al.. (2020). Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin. Bone Marrow Transplantation. 55(9). 1834–1836. 3 indexed citations
6.
Manceau, Sandra, Jean‐Sébastien Diana, Laure Joseph, et al.. (2020). Vascular access for optimal hematopoietic stem cell collection. Journal of Clinical Apheresis. 36(1). 12–19. 9 indexed citations
7.
Marçais, Ambroise, Ludovic Lhermitte, Maria Artesi, et al.. (2020). Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype. Leukemia. 35(3). 764–776. 21 indexed citations
8.
Mondésir, Johanna, David Sibon, Lise Willems, et al.. (2019). Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study. British Journal of Haematology. 187(1). 65–72. 1 indexed citations
9.
Sibon, David, Norbert Schmitz, Ritsuro Suzuki, et al.. (2019). ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients. Haematologica. 104(12). e562–e565. 41 indexed citations
10.
Derrieux, Coralie, Amélie Trinquand, Julie Bruneau, et al.. (2018). A Single-Tube, EuroClonality-Inspired, TRG Clonality Multiplex PCR Aids Management of Patients with Enteropathic Diseases, including from Formaldehyde-Fixed, Paraffin-Embedded Tissues. Journal of Molecular Diagnostics. 21(1). 111–122. 7 indexed citations
11.
Morel, Alexandre, Josette Brière, Laurence Lamant, et al.. (2017). Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study. European Journal of Cancer. 83. 146–153. 15 indexed citations
12.
Sibon, David, Franck Morschhauser, Matthieu Resche‐Rigon, et al.. (2015). Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group. Haematologica. 101(4). 474–481. 28 indexed citations
13.
Molina, Thierry Jo, et al.. (2013). Autoimmune Hemolytic Anemia and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Rare Association. SHILAP Revista de lepidopterología. 2013. 1–5. 4 indexed citations
14.
Sibon, David, Maroun Karam, Marie‐Hélène Delfau‐Larue, et al.. (2011). HTLV‐1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells. International Journal of Cancer. 131(4). 821–833. 8 indexed citations
15.
Bouaziz, Jean‐David, Maxime Battistella, David Sibon, et al.. (2011). Two Atypical Cases of Cutaneous Gamma/Delta T-Cell Lymphomas. Dermatology. 222(4). 297–303. 20 indexed citations
16.
Romero, Martha, Josette Brière, C. de Bazelaire, et al.. (2011). Aflibercept-mediated early angiogenic changes in aggressive B-cell lymphoma. Cancer Chemotherapy and Pharmacology. 68(5). 1135–1143. 4 indexed citations
17.
Poncet, Delphine, David Pérol, Claude Preudhomme, et al.. (2010). Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. Experimental Hematology. 39(2). 195–202.e2. 35 indexed citations
18.
19.
Biasoli, Irène, David Sibon, Josette Brière, et al.. (2008). Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapy. Annals of Oncology. 19(11). 1915–1920. 6 indexed citations
20.
Gabet, Anne‐Sophie, Vincent Moulés, David Sibon, et al.. (2005). Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication. Virology. 345(1). 13–21. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youko Suehiro Breakdown of academic impact, for papers by Dan Lehmann Breakdown of academic impact, for papers by Ciro Manzo Breakdown of academic impact, for papers by T Kitani Breakdown of academic impact, for papers by Caroline Thielen Breakdown of academic impact, for papers by Véra Boulay Breakdown of academic impact, for papers by Neil Minton Breakdown of academic impact, for papers by Mara Giordano Breakdown of academic impact, for papers by Marte K. Viken Breakdown of academic impact, for papers by Carsten Alt
Rankless by CCL
2026